Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folate Supplementation in Schizophrenia
NCT00249288Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2003
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of folic acid in schizophrenia, sponsored by Massachusetts General Hospital. Started Dec 2003; status: completed.
02
Drugs
folic acid
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00249288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249288.